CMS Open Payments · Program Year 2024
Sealonix Inc.
Sealonix Inc. reported $186,915.17 across General Payments, Research, and Ownership to 19 physicians and teaching hospitals across 31 transactions.
- $186.9K
- All-tracks total
- 31
- Transactions
- 19
- Recipients
- #1022
- of 1,925 companies
Sealonix Inc. reported $186,915.17 across all CMS Open Payments tracks (General + Research + Ownership) to 19 physicians and teaching hospitals in Program Year 2024 - ranking #1022 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $44,888.42, averaging $9.8K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer sealonix-inc Sealonix Inc.
$186.9K · #1022/1,925 · 0.0% industry · PY2024
- TOT $186.9K
- RANK #1022
- SHARE 0.0%
- TXN 31
- RCP 19
- CAT 3
- GEN $44.9K
- TOP1 79.6%
- PY 2024
Volume peers
Nearest volume peer: Reichert, Inc. ($186.8K)
Sealonix Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Sealonix Inc.
$186,915.17: that is what Sealonix Inc. reported in payments to 19 physicians and teaching hospitals during Program Year 2024, spread across 31 transactions ($6.0K per transaction, $9.8K per recipient). The company sits at rank #1022 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
6 transactions worth $35.7K make "Space Rental or Facility Fees" the top general-payment category in the 3-category breakdown below, 79.6% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Sealonix Inc. made 3 types of general payments. "Space Rental or Facility Fees" is the largest category at $35.7K, 79.6% of General Payments.
How Sealonix Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Space Rental or Facility Fees | $35.7K | 6 | 79.6% |
| Travel and Lodging | $6.7K | 10 | 14.8% |
| Consulting Fee | $2.5K | 3 | 5.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $40,976.11 (91.3%) of $44,888.42 in this company's General Payments records across 12 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sealonix Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Tufts Medical Center
$35,712.55 across 6 reported transactions
- 2
Benjamin P Johnson
$2,000.00 across 2 reported transactions
- 3
Mohd Raashid a Sheikh
$1,280.44 across 2 reported transactions
- 4
Shankar Lakshman
$1,073.72 across 1 reported transactions
- 5
Gaurav Bharti
$909.40 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Sealonix Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Sealonix Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Sealonix Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Fisher Scientific Company L.L.C.
Kulzer, LLC
VEO Ophthalmics
Maquet Cardiovascular L.L.C.
AppliedVR Inc
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.